Leflunomide-induced pulmonary arterial hypertension: Case report and review of literature.
暂无分享,去创建一个
G. Sinagra | E. Di Poi | M. Imazio | V. Patruno | C. Nalli | M. Driussi | D. Stolfo | L. Cereser | M. Baldassi | Valentino Collini | Francesco Giuliana
[1] M. Humbert,et al. Association between Leflunomide and Pulmonary Hypertension. , 2021, Annals of the American Thoracic Society.
[2] M. Humbert,et al. Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance–pharmacodynamic study , 2019, European Respiratory Journal.
[3] G. Simonneau,et al. An overview of the 6th World Symposium on Pulmonary Hypertension , 2019, European Respiratory Journal.
[4] Paul G. Williams,et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.
[5] C. Chabanne,et al. Pulmonary arterial hypertension in four patients treated by leflunomide. , 2018, Joint, bone, spine : revue du rhumatisme.
[6] Leflunomide , 2018, Reactions Weekly.
[7] P. Alvarez,et al. Leflunomide-Induced Pulmonary Hypertension in a Young Woman with Rheumatoid Arthritis: A Case Report , 2012, Cardiovascular Toxicology.
[8] S. Schissel,et al. Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells , 2008, Circulation.
[9] J. Armijo,et al. Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide. , 2004, Rheumatology.